In this episode of Skin Anarchy, host Dr. Ekta welcomes Maxwell Stock, founder and CEO of Epicutis, to explore the brand’s science-first approach to skin health and its latest innovation, the Arctigenin Brightening Treatment (ABT). Known for its minimalist, results-driven formulations, Epicutis is redefining professional skincare.

Max shares how his personal struggles with reactive skin inspired him to create a line focused on reducing inflammation and improving skin health. Leveraging his biotech background, he developed Epicutis to prioritize quality, transparency, and efficacy over flashy marketing or "fluff" ingredients. Collaborating with experts like Masanori Tamura, Epicutis delivers clinically-backed products designed to strengthen the skin barrier and enhance its natural function.

A standout of the episode is the ABT, a groundbreaking brightening product six years in the making. Unlike harsh brightening agents like vitamin C, ABT harnesses arctigenin, a natural compound from burdock seed, to reduce melanin production gently and effectively. Safe for all skin types, including sensitive and skin of color, ABT represents the next generation of brightening treatments.

Max also discusses Epicutis’s professional-first philosophy, emphasizing education and expertise. By working with skincare professionals, the brand empowers consumers to make informed decisions about their skin health.

If you’re ready to shift your skincare focus from anti-aging to overall skin health, this episode offers a deep dive into Epicutis’s innovative, science-driven solutions that deliver results without compromise. Tune in to discover how Epicutis is elevating skincare with integrity and simplicity.

To learn more about Epicutis, visit their website and social media. Don’t forget to subscribe to Skincare Anarchy on Apple Podcasts, Spotify, or your preferred platform. Reach out to us through email with any questions.

Shop all our episodes and products mentioned through our ShopMy Shelf!

Hosted on Acast. See acast.com/privacy for more information.